Role of reactive aldehyde in cardiovascular diseases.
By K. Uchida. Free Radical Biology & Medicine, 2000
606 citations recorded by the source corpus.
Subfields: Biochemistry, Clinical Biochemistry, Immunology
View Paper: https://www.semanticscholar.org/paper/941b91819f91dcd9f0bcf8c637de55f508282bf0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biochemistry
In Clinical Biochemistry
In Immunology
Citations in the corpus
- Dietary factors and low-grade inflammation in relation to overweight and obesity (2011, neutral): “Major contributors to any anti-inflammatory activity of nuts are likely to include PUFA, Mg and phytochemicals including ellagic acid(372).”
- Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal (2014, neutral): “Cardiovascular diseases MDA 4-HNE [72, 79, 109, 123, 135, 137–141] [72, 104, 109, 131, 135, 138, 139, 142–144]”
- Biological markers of oxidative stress: Applications to cardiovascular research and practice (2013, background): “MDA's reaction with lysine residues generates lysine – lysine cross-links [31] which have been identi fi ed in apolipoprotein B (apoB) fractions of oxidized low density lipoprotein (OxLDL), and have been postulated to impair the interaction between OxLDL and macrophages and thereby to promote…”
- Biomarkers of oxidative damage in human disease. (2006, neutral): “Cardiovascular disease (57) Cataract genesis (90)”
- Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors (2008, background): “Beside their metabolic deviation, oxLDLs exhibit a large variety of biological and atherogenic properties involved in the activation of inflammatory, mitogenic or proapoptotic pathways (Hajjar and Haberland, 1997; Uchida, 2000).”
- Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. (2004, background): “The potential significance of elevated aldehyde concentrations is clearly demonstrated by their prominent role in the pathogenesis of atherosclerosis [38, 39].”
- Aldehyde Sources, Metabolism, Molecular Toxicity Mechanisms, and Possible Effects on Human Health (2005, background): “…leading to tissue deterioration also occured in several pathological conditions other than diabetes toxicity (Singh et al., 2001b), such as cardiovascular diseases including atherosclerosis (Baynes et al., 2000; Uchida, 2000) and uremia (Miyata et al., 2001), which also increased with aging.”
- The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. (2002, background): “UREMIA, OXIDATIVE STRESS, AND ALDEHYDE FORMATION Reactive aldehydes can be formed as the end product of a variety of oxidative reactions including oxidation of alcohol groups, amino groups, and via the addition of oxygen to unsaturated carbon double bonds in carbohydrates, lipids, or amino acids ”
- A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. (2005, background): “5) [3].”